Association Between Low-Density Lipoprotein Cholesterol–Lowering Genetic Variants and Risk of Type 2 Diabetes

  • Luca A. Lotta
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Stephen J. Sharp
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Stephen Burgess
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
  • John R. B. Perry
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Isobel D. Stewart
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Sara M. Willems
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Jian’an Luan
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Eva Ardanaz
    Navarre Public Health Institute, Pamplona, Spain4Navarra Institute for Health Research, Pamplona, Spain5CIBER Epidemiología y Salud Pública, Madrid, Spain
  • Larraitz Arriola
    CIBER Epidemiología y Salud Pública, Madrid, Spain6Public Health Division of Gipuzkoa, San Sebastian, Spain7Instituto BIO-Donostia, Basque Government, San Sebastian, Spain
  • Beverley Balkau
    Inserm, CESP, U1018, Villejuif, France9Université of Paris-Sud, UMRS 1018, Villejuif, France
  • Heiner Boeing
    German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany
  • Panos Deloukas
    Wellcome Trust Sanger Institute, Cambridge, United Kingdom
  • Nita G. Forouhi
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Paul W. Franks
    Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, Sweden13Umeå University, Umeå, Sweden
  • Sara Grioni
    Epidemiology and Prevention Unit, Milan, Italy
  • Rudolf Kaaks
    German Cancer Research Centre, Heidelberg, Germany
  • Timothy J. Key
    University of Oxford, Oxford, United Kingdom
  • Carmen Navarro
    CIBER Epidemiología y Salud Pública, Madrid, Spain17Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain18Unit of Preventive Medicine and Public Health, School of Medicine, University of Murcia, Murcia, Spain
  • Peter M. Nilsson
    Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, Sweden
  • Kim Overvad
    Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark20Aalborg University Hospital, Aalborg, Denmark
  • Domenico Palli
    Cancer Research and Prevention Institute, Florence, Italy
  • Salvatore Panico
    Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy
  • Jose-Ramón Quirós
    Public Health Directorate, Asturias, Spain
  • Elio Riboli
    School of Public Health, Imperial College London, London, United Kingdom
  • Olov Rolandsson
    Umeå University, Umeå, Sweden
  • Carlotta Sacerdote
    Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention, Turin, Italy26Human Genetics Foundation, Turin, Italy
  • Elena Salamanca-Fernandez
    CIBER Epidemiología y Salud Pública, Madrid, Spain27Andalusian School of Public Health, Granada, Spain28Instituto de Investigación Biosanitaria de Granada, Granada, Spain
  • Nadia Slimani
    International Agency for Research on Cancer, Lyon, France
  • Annemieke M. W. Spijkerman
    National Institute for Public Health and the Environment, Bilthoven, the Netherlands
  • Anne Tjonneland
    Danish Cancer Society Research Center, Copenhagen, Denmark
  • Rosario Tumino
    Azienda Sanitaria Provinciale di Ragusa, Ragusa, Italy
  • Daphne L. van der A
    National Institute for Public Health and the Environment, Bilthoven, the Netherlands
  • Yvonne T. van der Schouw
    University Medical Center Utrecht, Utrecht, the Netherlands
  • Mark I. McCarthy
    Oxford Centre for Diabetes, Endocrinology and Metabolism, and Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
  • Inês Barroso
    Wellcome Trust Sanger Institute, Cambridge, United Kingdom
  • Stephen O’Rahilly
    Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
  • David B. Savage
    Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
  • Naveed Sattar
    Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland
  • Claudia Langenberg
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Robert A. Scott
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
  • Nicholas J. Wareham
    MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom

書誌事項

タイトル別名
  • A Meta-analysis

収録刊行物

  • JAMA

    JAMA 316 (13), 1383-, 2016-10-04

    American Medical Association (AMA)

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ